Skip to Content Top


PMC and UCLA logo

Join Us for the 8th International Symposium on Malignant Pleural Mesothelioma Saturday, September 29th at the UCLA Luskin Center

Worthington & Caron, PC is proud to be lead sponsor of the The 8th International Mesothelioma Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma, where International Experts from around the world will meet to discuss the latest treatment options for mesothelioma.

The 8th International Symposium will be held Saturday, September 29th at the UCLA Meyer & Renee Luskin Conference Center in Los Angeles, California.

Course Chair, Dr. Robert Cameron, has over 30 years of experience treating patients with malignant pleural mesothelioma. He has played a vital role in the development of lung-sparing treatments including the pleurectomy/decortication surgery and a number of adjuvant therapies. Dr. Cameron serves as Director of the Comprehensive Mesothelioma Programs at UCLA Medical Center. He also serves as Scientific Advisor at the Pacific Mesothelioma Center.

Dr. Cameron will be joined by leading mesothelioma experts who will highlight recent advancements in mesothelioma treatment and cutting-edge research.

All physicians and nurses attending will receive continuing medical education (CME) course credit.

*Patients and families are welcome and encouraged to attend.

For more information, and to register, click here.

Presentations and Discussions:

  • Perioperative Immunotherapy: Surgery as Immunotherapy: Robert B. Cameron, MD, FACS
  • Mesothelioma Clinical Trials: Novel and Combination Systemic Therapies: Olga Olevsky, MD
  • An Exhaled Breath Biopsy Earmarks Exclusive Screening for Malignant Pleural Mesothelioma: Kevin Lamote, PhD
  • Novel MRI Assessment of Mesothelioma Tumor Volume: Kevin G. Blyth, MD, MBchB, FRCP
  • Toxicities and Outcomes Using Whole Pleural Intensity – Modulated Proton Therapy: Charles B. Simone II, MD
  • Understanding the Immune Response to Radiotherapy in a Dual Tumor Model of Mesothelioma: Wesley Wilson, PhD Candidate
  • Integrative Molecular Characterization of Mesothelioma: Cancer Genome Atlas Project: Marc Ladanyi, MD
  • The Immune Microenvironment: Focus on Macrophages and T-Cells as Regulators of Tumor Progression and Therapeutic Responses: Lisa M. Coussens, PhD
  • A Modified Measles Virus Against Mesothelioma: Oncolytic and Immunotherapeutic Potential: Nicolas Boisgerault, PhD
  • Immunotherapy using Gene Modified Mesenchymal Stem Cells: Masahide Tone, PhD
  • Overcoming the Immunosuppressive Tumor Microenvironment of Murine Malignant Mesothelioma: Mikihiro Kohno, MD, PhD